Phase II Study of 0.15% UF-021 in patients with retinitis pigmentosa
Phase 2
- Conditions
- retinitis pigmentosa
- Registration Number
- JPRN-jRCT2080220721
- Lead Sponsor
- R-Tech Ueno, Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 105
Inclusion Criteria
Decimal visual acuity: 0.5 or better
With abnormal visual field measured by the Goldmann perimetry
Exclusion Criteria
The subject has taken steroids and/or vasodilators within 1 month prior to informed consent.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method